Check out this exciting new publication on Early Intervention Services vs. treatment as Usual in Early Phase Psychosis.
NatCon18: April 23rd through 25th, Gaylord National Resort & Convention Center National Harbor, MD. Come visit us at booth 1132. We are excited to meet you and learn more about your organization! #NatCon2018
Vanguard Research Group, a Manhasset company owned by North Shore-Long Island Jewish Health System and one of its executives, has signed a four-year, $28.8 million agreement to manage a clinical trial for an injectable form of a schizophrenia drug.